title: Remote monitoring: a cost or an investment?
abstract: Remote management of pacemakers and implantable defibrillators is being increasingly used in Europe, due to its potential to improve follow-up efficiency and patient outcome. However, this paradigm shift needs to be economically viable for it to be sustainable in the long term. This article covers the economic aspects of remote device management, and reviews the current evidence in this field.
authors.affiliation: Cardiology Service, University Hospital of Geneva, Switzerland. haran.burri@hcuge.ch
authors.forename: Haran
authors.initials: H
authors.lastname: Burri
authors.forename: Hein
authors.initials: H
authors.lastname: Heidbüchel
authors.forename: Werner
authors.initials: W
authors.lastname: Jung
authors.forename: Pedro
authors.initials: P
authors.lastname: Brugada
mesh_terms: D001145:Arrhythmias, Cardiac / Q000191:economics* / Q000401:mortality / Q000517:prevention & control*; D058406:Cardiac Resynchronization Therapy / Q000191:economics* / Q000706:statistics & numerical data; D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care / Q000191:economics; D005060:Europe / Q000453:epidemiology; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D007449:Investments / Q000706:statistics & numerical data; D018670:Monitoring, Ambulatory / Q000191:economics* / Q000706:statistics & numerical data; D015995:Prevalence; D058998:Remote Sensing Technology / Q000191:economics* / Q000706:statistics & numerical data; D016019:Survival Analysis; D015996:Survival Rate; D017216:Telemedicine / Q000191:economics* / Q000706:statistics & numerical data